GLP1 receptor agonists and SGLT2 inhibitors may not only to some degree relieve symptoms of frank HF but instituted early may even halt and possibly reverse findings of fibrosis and vascular rarefaction. The gene discussed is GLP1R; the disease is hydrops fetalis.